These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24605725)

  • 41. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin lispro: a fast-acting insulin analog.
    Noble SL; Johnston E; Walton B
    Am Fam Physician; 1998 Jan; 57(2):279-86, 289-92. PubMed ID: 9456992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lantus reduces blood glucose levels, less hypoglycemia in treatment of type 2 diabetes.
    Walczak IM
    Diabetes Technol Ther; 2002; 4(5):735-6. PubMed ID: 12458566
    [No Abstract]   [Full Text] [Related]  

  • 44. Oral insulin - a review of current status.
    Iyer H; Khedkar A; Verma M
    Diabetes Obes Metab; 2010 Mar; 12(3):179-85. PubMed ID: 20151994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrating advances in insulin into clinical practice: Advances In insulin formulations.
    King A
    J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S9-17. PubMed ID: 24080573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of moderate intensity glycemic control after cardiac surgery.
    Leibowitz G; Raizman E; Brezis M; Glaser B; Raz I; Shapira O
    Ann Thorac Surg; 2010 Dec; 90(6):1825-32. PubMed ID: 21095319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypoglycemia--a dreaded complication of diabetes].
    Bjørgaas M
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2441-4. PubMed ID: 11475234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Closer to ideal insulin action: ultra fast acting insulins.
    Cengiz E
    Panminerva Med; 2013 Sep; 55(3):269-75. PubMed ID: 24088800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Approach to managing hypoglycemia in elderly patients with diabetes.
    Alagiakrishnan K; Mereu L
    Postgrad Med; 2010 May; 122(3):129-37. PubMed ID: 20463422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.
    Bailey T; Campos C
    Expert Rev Med Devices; 2012 May; 9(3):209-17. PubMed ID: 22471783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral Insulin Delivery in a Physiologic Context: Review.
    Arbit E; Kidron M
    J Diabetes Sci Technol; 2017 Jul; 11(4):825-832. PubMed ID: 28654313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Reference Guide to Integrate Smart Insulin Pens Into Data-Driven Diabetes Care and Education Services.
    Warshaw H; Isaacs D; MacLeod J
    Diabetes Educ; 2020 Aug; 46(4_suppl):3S-20S. PubMed ID: 32779975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comment on "Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long acting versus short-acting insulins?".
    Pfützner A
    J Diabetes Sci Technol; 2011 Nov; 5(6):1627-8. PubMed ID: 22226291
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial: nanotechnology as a strategy to improve treatment of diabetes.
    Ribeiro AJ
    Curr Pharm Biotechnol; 2014; 15(7):589. PubMed ID: 25219862
    [No Abstract]   [Full Text] [Related]  

  • 55. New perspectives on insulin therapy.
    Araki E; Araki H; Senokuchi T; Motoshima H
    J Diabetes Investig; 2020 Jul; 11(4):795-797. PubMed ID: 32232932
    [No Abstract]   [Full Text] [Related]  

  • 56. Feigned insulin reactions in diabetic children prevented by glucagon.
    HAUNZ EA
    J Lancet; 1962 Jun; 82():263-8. PubMed ID: 13905412
    [No Abstract]   [Full Text] [Related]  

  • 57. Imaging and therapy of diabetes: State of the art.
    Cai W; Davis DB
    Adv Drug Deliv Rev; 2019 Jan; 139():1-2. PubMed ID: 31375196
    [No Abstract]   [Full Text] [Related]  

  • 58. Insulin hypoglycaemia and the eosinophil-count.
    SHATTOCK FM; MICKLEM LP
    Lancet; 1952 Jun; 1(6721):1239-40. PubMed ID: 14939774
    [No Abstract]   [Full Text] [Related]  

  • 59. The effects of insulin hypoglycemia on the diabetic heart.
    CHITWOOD WR
    Va Med Mon (1918); 1953 Mar; 80(3):168-70. PubMed ID: 13039269
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Fractionated insulins.
    Oakley N
    Lancet; 1976 Jun; 1(7973):1355. PubMed ID: 58349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.